LEUKAEMIA DRUG

Motion Text

That this House welcomes the National Institute for Clinical Excellence's provisional recommendation that Glivec should be available on the NHS as a first-line treatment of people with chronic myeloid leukaemia in the chronic phase; and calls on NICE to issue final guidance as soon as possible.